MRI Fusion Guided Prostate Biopsy

MRI Fusion Guided Prostate Biopsy

The MRI fusion guided prostate biopsy “fuses” MRI scans with real-time ultrasound images of the prostate. This cutting-edge biopsy system allows us here at the Dr. David Samadi Prostate Cancer Center to pinpoint specific tumors within the prostate gland. This information provides the patient with the most optimal treatment plan and best possible outcome in detecting and diagnosing prostate cancer.

Read More

Understanding Prostate Cancer

Understanding Prostate Cancer

Prostate cancer is one of the most common types of cancer in men. It starts in the prostate gland, which is a small walnut-shaped gland that is responsible for the production of seminal fluid. Prostate cancer is often a slow growing disease, but in some cases and depending on certain risk factors, it can be an aggressive disease and spread rather quickly. 

Read More

Distress Factors in Newly Diagnosed Prostate Cancer Patients

Distress Factors in Newly Diagnosed Prostate Cancer Patients

A study, published in the journal Psycho-Oncology, analyzed four different areas that could contribute to prostate cancer patient psychological distress. The researchers from New York's University of Buffalo, looked at factors like prognosis, individual beliefs, personality resources and demographics. 

Read More

USPSTF guidelines puts men in danger

USPSTF guidelines puts men in danger

The U.S. Preventive Services Task Force recommends against PSA (prostate specific antigen) screening for prostate cancer. The task force currently gives PSA screening a grade D, meaning that there is moderate or high certainty that the PSA test has no benefit or that the harms outweigh the benefits. This recommendation was first issued in 2011.

Read More

Statin & metformin combination reduces prostate cancer death risk

Statin & metformin combination reduces prostate cancer death risk

A new study from suggests that statins either alone or in combination with metformin may reduce the risk of dying from prostate cancer. The study’s findings were presented at the American Society of Clinical Oncology annual meeting in Chicago. The study was carried out by Grace L. Lu-Yao, PhD, an epidemiologist at the Rutgers Cancer Institute of New Jersey in New Brunswick.

Read More

New study finds genetic anomalies in advanced prostate cancer patients

New study finds genetic anomalies in advanced prostate cancer patients

A new study carried out by a collaboration of international research teams shows genetic anomalies in biopsy samples from patients with advanced prostate cancer through a large multi-institutional integrative clinical sequencing approach. Here's what you need to know.

Read More